期刊文献+

“流体力学转染”——安全高效的动物活体器官基因转染方法 被引量:1

Hydrodynamics-Based Transfection:A Simple,Convenient and Efficient in vivo Transgene Method
原文传递
导出
摘要 作为一种新的简便而高效的动物活体基因转染方法,“流体力学转染”技术正日益成为生物遗传学家们进行基因研究的重要工具。该技术利用“流体力学”原理,通过裸质粒溶液的静脉注射,实现了活体肝靶向性的基因转染。“流体力学”注射后所造成的肝窗扩大和肝细胞膜通透性的增加,可能是肝内基因有效转染的重要机制。目前“流体力学方法”在基因研究的各个领域都得到了广泛的应用,文章重点介绍了该方法在基因功能、疾病基因治疗和获得基因产物等几个方面研究中的应用。同时也简要介绍了增强外源基因在靶器官内表达的进展。 As a simple, convenient and efficient in vivo transgene method, hydrodynamics-based transfection provides biogeneticists with an important tool for gene study. High levels of foreign gene expression in liver can be achieved by rapid tail vein injection of a large volume of a naked DNA ment mech procedure has been used in many fields of gene studies, including gene function study, disease treatment, gene product obtaining etc. The article also covers the methods for the in vivo enhancement of exogenous gene expression in target organs.
出处 《医学分子生物学杂志》 CAS CSCD 2006年第6期426-429,共4页 Journal of Medical Molecular Biology
基金 国家自然科学基金(No.30660066 30360037 30160032)~~
关键词 流体力学转染 肝靶向性 机制 应用 hydrodynamics-based transfection liver-targeted mechanism application
  • 相关文献

参考文献2

  • 1Yumi Matsui,Naoki Kobayashi,Makiya Nishikawa,Yoshinobu Takakura. Sequence-Specific Suppression of mdr1a/1b Expression in Mice via RNA Interference[J] 2005,Pharmaceutical Research(12):2091~2098
  • 2Hiroki Maruyama MD,Noboru Higuchi,Shigemi Kameda,Jun-ichi Miyazaki,Fumitake Gejyo. Rat liver-targeted naked plasmid DNA transfer by tail vein injection[J] 2004,Molecular Biotechnology(2):165~172

同被引文献8

  • 1张志珍,毛积芳,杨生生.重组人胰高血糖素样肽-1对实验性糖尿病大鼠血糖的影响[J].中国生化药物杂志,2004,25(5):287-290. 被引量:5
  • 2刘亮明,罗杰,张吉翔,郭宏兴,邓欢,徐江晶,尹东,熊高飞.鼠尾静脉流体力学转染技术对绿色荧光蛋白表达质粒器官靶向分布的影响[J].中国组织工程研究与临床康复,2007,11(23):4558-4561. 被引量:6
  • 3Poomima I, Brown SB, Bhashyam S, et al. Chronic glucagon-like peptide-1 (GLP-1) infusion sustains LV systolic function and prolongs survival in the spontaneously hypertensive heart failure prone rat[J]. Circ Heart Fail, 2008, 1(3): 153-160.
  • 4Khoo J, Rayner CK, Jones KL, et al. Incretin-based therapies:new treatment for type 2 diabetes in the new millennium[J]. Ther din Risk Manaq, 2009, 5(3): 683-698.
  • 5Yu YL, Lu SS, Yu S, et al. Huang-lian-jie-du-decoetion modulates glucagon-like pepfide-1 secretion in diabetic rats[J]. J Ethnopharrna col, 2009, 124(3): 444-449.
  • 6Comu M, Yang JY, Jaccard E, et al. Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop[J]. Diabetes, 2009, 58(8): 1816-1825.
  • 7Buteau J, El-Assaad W, Rhodes CJ, et al. Glucagon-like peptide-1 prevents beta cell glucolipotoxicity[J]. Diabetologia, 2004, 47(5): 806-815.
  • 8李晓丽,刘振,张志珍.人胰高血糖素样肽-1类似物基因克隆及真核表达载体构建[J].中国现代医学杂志,2009,19(20):3046-3049. 被引量:5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部